(Q36039063)

11 August 2017

1 reference

title

Antecedents to effective treatment of hypertension in Hispanic populations (English)

1 reference

11 August 2017

Maria L Soto-Greene

1

1 reference

11 August 2017

Debbie Salas-Lopez

series ordinal

2

1 reference

11 August 2017

Jorge Sanchez

series ordinal

3

1 reference

11 August 2017

Robert C Like

series ordinal

4

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

6

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

30-6; discussion 37-8

1 reference

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Suboptimal outcome of management of metabolic cardiovascular risk factors in Hispanic patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Excess incidence of treatment of end-stage renal disease in Mexican Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Diabetes, gallbladder disease, obesity, and hypertension among Hispanics in New Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Prevalence of hypertension in Hispanic and non-Hispanic white populations

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Hypertension prevalence and the status of awareness, treatment, and control in the Hispanic Health and Nutrition Examination Survey (HHANES), 1982-84

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Undertreatment of hypertension in older Mexican Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Awareness of hypertension and diabetes in the Hispanic community

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Hypertension in multicultural and minority populations: linking communication to compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Barriers to health promotion and disease prevention in the Latino population

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Cultural marginality: a concept analysis with implications for immigrant adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

CYP2D6 polymorphism in a Mexican American population

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Do ethnic differences in dietary cation intake explain ethnic differences in hypertension prevalence? Results from a cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Calcium intakes of Mexican Americans, Cubans, Puerto Ricans, non-Hispanic whites, and non-Hispanic blacks in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

The place of combination therapy in the treatment of hypertension in 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

Combination therapy as first-line treatment for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2804%2980062-0

7 January 2021

10.1016/S1098-3597(04)80062-0

Identifiers

DOI

1 reference

11 August 2017

1 reference